Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04089553
Title An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications

prostate cancer

Therapies

AZD4635 + Durvalumab

AZD4635 + Oleclumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Denver Colorado 80218 United States Details
Research Site Fort Myers Florida 33916 United States Details
Research Site Saint Petersburg Florida 33705 United States Details
Research Site West Palm Beach Florida 33401 United States Details
Research Site Decatur Illinois 62526 United States Details
Research Site New York New York 10032 United States Details
Research Site Durham North Carolina 27710 United States Details
Research Site Chattanooga Tennessee 37404 United States Details
Research Site Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field